Why this matters now: India now hosts more than 2,100 Global Capability Centers, with healthcare-biotech among the fastest-growing sectors. Roughly 80% of new GCCs launching in 2026 carry an AI-first mandate. At the same time, US healthcare engineering costs have risen faster than IT budgets for four consecutive years, creating pressure to expand offshore. The entry model decision (BOT, Managed Pod, or staff augmentation) is not a sourcing choice. It determines who owns the IP, whether HIPAA-compliant infrastructure is in place from day one, and whether the India program builds compounding value or just reduces a line item.

Why US healthcare firms are expanding into India now

Three things are converging at once. The cost of US-based healthcare engineering talent, particularly for AI/ML, data engineering, and interoperability roles, has risen well above inflation for four straight years. Second, India's healthcare and health-tech engineering talent pool has reached a point where it can support sophisticated work: FHIR integration, HL7 pipeline development, prior authorization AI, clinical NLP. Third, the regulatory environment in the US is generating a wave of new system requirements. The 21st Century Cures Act, ONC interoperability rules, and prior authorization automation mandates are creating work that healthcare organizations need to build against quickly and at scale.

The result is that healthcare firms which might have treated India expansion as a five-year consideration are treating it as a 12-month decision. The question is no longer whether to build in India. It is which model to use.

Getting that model wrong costs more than the savings. A US healthcare firm that uses staff augmentation for work that requires institutional context ends up with contributors who cannot build on each other's knowledge. A firm that commits to a BOT before it has a 50-engineer pipeline discovers that the entity setup, compliance infrastructure, and transition overhead consume the cost savings for the first two years. A firm that chooses a Managed Pod but leaves IP ownership terms undefined finds itself renegotiating that contract at the worst possible time.

"The entry model decision is not a sourcing choice. It determines who owns what the India team builds, and whether that ownership transfers to you on day one or after a 24-month program."
2,100+
GCCs operating in India today, with healthcare-biotech at double-digit share and growing faster than the GCC average. India added more than 200 new GCCs in 2025 alone
60-70%
Typical cost savings vs. equivalent US engineering talent across software, data, and AI roles, after accounting for management overhead, attrition, and compliance infrastructure
18-24 mo
Minimum realistic timeline for a BOT program to reach transfer readiness. Organizations that plan for 12 months routinely discover entity setup, compliance buildout, and knowledge transfer take longer

BOT, Managed Pod, and Staff-Aug compared across what actually matters

The three models look different on paper and very different in practice. The comparison that matters for a US healthcare firm is not cost per engineer. It is HIPAA posture from day one, who owns the IP produced, how much management overhead transfers onshore, and what happens to the program if the relationship needs to change.

Decision FactorStaff AugmentationManaged PodBOT (Build-Operate-Transfer)Healthcare Risk
Time to first engineer2 to 4 weeks. Fastest path to headcount. Individual contributors placed through a staffing firm4 to 8 weeks. Team assembled and onboarded as a unit with shared context and a delivery lead3 to 6 months. Legal entity registration, compliance infrastructure, and team build happen in parallel before the first hire is placedPlan ahead
HIPAA postureWeakest. BAA often covers the staffing firm only. Individual contributor's work environment and data access are rarely reviewed by the healthcare organization's security teamProvider-managed. BAA covers the pod operator. Security architecture, PHI access controls, and audit logging are the provider's responsibility and should be reviewed before engagementOrganization-controlled from transfer. During the operate phase, HIPAA posture depends on provider architecture. Post-transfer, the organization owns and operates it directlyCritical
IP ownershipContractually complex. IP provisions vary by staffing agreement. Work-for-hire clauses need explicit review. Offshore IP assignment is not automatic under Indian lawDefined by contract. Most managed pod agreements assign IP to the client by default, but "default" varies. Verify the IP clause before signing, not after the first sprintFull ownership post-transfer. During the operate phase, IP accrues to the engagement. At transfer, the organization takes full ownership of the team, systems, and all produced IPHigh
Management overheadHighest for the client. Each augmented contributor requires US-side management, context-setting, and performance oversight. Works at 1 to 5 engineers; breaks down at 15+Moderate. The pod delivery lead manages day-to-day. Client sets direction and reviews output. Effective for teams of 5 to 40 engineers when the pod model is set up correctlyShared during build and operate phases. Transfers fully to the client at handover. Post-transfer overhead is equivalent to running a captive GCC, which requires in-house India leadershipModerate
Attrition riskHighest. Individual contributors placed through staffing firms have no team loyalty and face constant competing offers. India technology attrition averages 18 to 25% per year in staffing arrangementsLower than staffing. Team cohesion and provider employment model reduce churn. Attrition in well-run managed pods runs 10 to 14% annually, closer to GCC normsLowest post-transfer. During operate phase, attrition risk is the provider's problem. Post-transfer, the organization controls compensation and career path, typically achieving 8 to 12% annual attritionHigh
Exit flexibilityHigh. Staffing arrangements typically have 30-day notice periods. Easy to scale down. No stranded infrastructure or legal entity to dissolveModerate. Contract terms typically run 12 to 24 months with structured wind-down provisions. Transitioning to a different provider requires knowledge transfer planningLow during operate phase. BOT commitments are typically 2 to 3 year engagements. Early exit before transfer triggers contractual penalties and leaves the organization with an incomplete buildModerate

Not sure which India entry model fits your healthcare program?

10decoders has delivered all three models for US healthcare organizations, from 2-engineer staff-aug integrations to full BOT programs with HIPAA-compliant GCC infrastructure. Our India entry assessment maps your headcount targets, HIPAA requirements, and IP ownership priorities to the model that fits your situation, not the model that is easiest to sell you.

Book a Free AI Assessment →

When each model makes sense for a US healthcare firm

Staff augmentation works when you have a specific skill gap, a short time horizon, and a US-based team that can absorb and direct individual contributors without adding management capacity. A healthcare organization that needs two FHIR developers for a six-month interoperability project is a reasonable staff-aug case. A healthcare organization that needs to build an AI documentation team, a data engineering practice, or a claims automation capability is not. Those programs require context, continuity, and team learning. Individual contributors cycling through a staffing arrangement cannot provide any of those things at the rate the work demands.

Managed Pod is the right model for most US healthcare firms at the 10 to 40 engineer scale. The pod operates as a team with shared context, a delivery lead who handles day-to-day management, and a provider who owns the India-side HR, compliance, and infrastructure. The client retains strategic direction, IP ownership, and output accountability. For healthcare specifically, the critical check is whether the provider can demonstrate a HIPAA-compliant work environment, a signed BAA covering PHI handling, and security architecture that your compliance team can review. Most general-purpose managed pod providers cannot pass that check. Providers with a healthcare practice can.

BOT is the right model for organizations with a long-term India commitment, a target team size above 50 engineers, and the internal leadership capacity to run a captive GCC after transfer. The economics of a BOT improve significantly at scale. Below 30 engineers, the entity setup, compliance infrastructure, and transition overhead often consume the cost advantage of owning the team directly. Above 50 engineers, the compounding IP and talent ownership justify the 18 to 24 month build-and-operate investment. The key question is not whether a BOT is the right model in principle. It is whether the organization is prepared to operate a captive GCC on the other side of the transfer.

Model 1
Best for: 1-10 engineers, defined scope

Staff Augmentation

Individual contributors placed through a staffing firm. US team manages directly. Fast to start, easy to exit. HIPAA posture requires explicit review. Works for short-term skill gaps, not for building institutional AI capability.

Model 2
Best for: 10-40 engineers, ongoing program

Managed Pod

Pre-assembled team managed by a provider with healthcare expertise. Client owns IP and direction. Provider owns HR, security, and compliance infrastructure. HIPAA posture covered by BAA with the provider. Right model for most healthcare AI and data programs.

Model 3
Best for: 50+ engineers, long-term commitment

BOT (Build-Operate-Transfer)

Provider builds and operates the GCC for 18 to 24 months, then transfers full ownership. Organization ends up with a captive entity, owned talent, and full IP. Requires internal leadership capacity to run post-transfer. Highest long-term value at scale.

What US healthcare firms get wrong about India entry

India Entry Decision Checklist for US Healthcare Firms
Define your 36-month headcount target before choosing a modelThe model that makes sense at 8 engineers does not make sense at 35, and the model that makes sense at 35 does not make sense at 80. Choose the model for where you are going, not where you are starting. If you do not know your 36-month target, that uncertainty is itself information: start with a Managed Pod that can transition to BOT rather than committing to a structure built around a headcount you have not validated.
Confirm data flow and HIPAA requirements before signing any India agreementWork through your compliance team to determine what patient data, claims data, and clinical content will flow to the India team. Map each data category to its HIPAA classification. Then verify that the provider you are evaluating can demonstrate the security architecture, audit logging, PHI segregation, and Business Associate Agreement coverage required for each category. Do this before contract signature, not during onboarding.
Read the IP ownership clause, not the summary sheetIn a Managed Pod arrangement, "IP is yours" in a sales deck can mean something very different from what the contract says about background IP, derivative works, and offshore IP assignment under Indian law. Have legal review the actual IP clause in the MSA, not the one-pager. This is especially important for healthcare AI programs where the extraction models, agent evaluation sets, and trained classifiers represent significant accumulated value.
Do not use staff augmentation for AI/data roles that require institutional contextHealthcare AI programs (claims prediction, clinical NLP, prior authorization automation, EMR documentation AI) require engineers who understand the data model, the business logic, and the regulatory context of the work. That context takes months to build. An augmented contributor placed through a staffing firm and managed remotely by a US team will spend their first 60 days learning what a permanent team member already knows. The model is wrong for the work.
Build attrition into your cost model, not as a footnoteIndia technology attrition in staffing arrangements runs 18 to 25% per year. In Managed Pod programs with healthcare providers, it runs 10 to 14%. In captive GCCs, it runs 8 to 12%. The difference between 25% and 10% annual attrition on a 20-engineer team is 3 replacement hires per year instead of 5. Each replacement hire costs 1.5 to 2 months of productivity. Run those numbers in your cost model before deciding the cheapest day-rate is the right choice.
Plan for the BOT transfer before you start the operate phaseThe most common BOT failure mode is not during build or operate. It is at transfer. Organizations that plan the transfer event only after the operate phase is complete discover that their US leadership team does not have the India management capacity to absorb the GCC, that the compliance infrastructure needs significant rework to meet enterprise standards, or that key engineers on the India team have left in the months before handover. Transfer readiness planning should start at month six of the operate phase, not month eighteen.
Treat India entry as a capability investment, not a cost reduction programHealthcare organizations that enter India to cut costs build teams optimized for cost. Healthcare organizations that enter India to build AI capability build teams optimized for output quality, IP accumulation, and program compounding. The second group consistently outperforms the first on three-year ROI because they attracted better engineers, retained them longer, and built institutional knowledge that the cost-optimization teams could not replicate. The mandate you set at entry determines which group you end up in.
"The healthcare organizations that get the most from their India programs are not the ones that found the cheapest engineers. They are the ones that chose the right model for the scale they were building toward."

What to do this week

01Write down your India headcount target for 12 months and 36 months

This exercise takes 30 minutes and makes every other India entry decision clearer. Start with the programs you are running or planning in the next 12 months that would benefit from India-based talent: AI/ML engineering, FHIR integration, data pipeline, revenue cycle automation. Estimate the team size each program needs. Sum to a 12-month number. Then project 36 months if the programs succeed. If the 12-month number is under 10, the Managed Pod model covers it. If the 36-month number is above 50, start a BOT conversation now because the 18 to 24 month lead time means you should be starting the design phase before you hit that headcount ceiling.

02Confirm with your compliance team whether PHI can flow to an India-based team under your current BAA framework

This check takes one meeting and prevents a significant rework later. Ask your compliance team whether your existing Business Associate Agreements cover offshore subcontractors, and if so, what security architecture those subcontractors are required to demonstrate. If your existing BAAs do not cover offshore PHI handling, you will need new agreement terms before any patient data moves. Knowing this before you select a provider means you can include it as a requirement in the evaluation, rather than discovering it after contracts are signed.

03Ask your US engineering leads what institutional context an India team would need to be productive

The most underestimated cost in India entry is context transfer. Ask two or three of your US engineering leads to describe what a new engineer joining their team needs to understand before they can contribute independently. How long does that take? What documentation exists? What is in people's heads that is not written down? The answers tell you whether your programs are staff-aug-compatible (simple, well-documented, low context dependency) or require a Managed Pod or BOT (complex, evolving, high institutional knowledge). Most healthcare AI programs fall in the second category.

04Evaluate one provider per model and compare them on HIPAA posture, not day rate

Before making an India entry decision, get a response from one provider in each category: a staffing firm, a managed pod provider with a healthcare practice, and a BOT provider with GCC experience in India. Ask each one the same four questions: what does your BAA cover for PHI handling, how do you demonstrate HIPAA-compliant security architecture to a client's compliance team, what does your IP ownership clause say about derivative works and offshore assignment, and what is your last 12-month attrition rate for healthcare programs? The quality of the answers will sort the providers faster than any RFP scorecard.

Let 10decoders design your India entry model

We have delivered all three models for US healthcare organizations, from targeted staff-aug integrations to full BOT programs with HIPAA-compliant GCC infrastructure. Our India entry assessment maps your headcount targets, compliance requirements, and IP ownership priorities to the right model, with a phased plan that keeps your options open as the program scales. 200+ engineers across Charlotte, Chennai, Madurai, and Singapore. ISO 27001 and ISO 9001 certified.